Recombinant Human Growth Hormone Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 154 Category: Pharma & Healthcare Report Code : HC0316549
Recombinant Human Growth Hormone Market by Type(Powder, Solvent) Application (Growth Hormone Deficiency (GHD), Chronic Renal Insufficiency, Turner Syndrome, SHOX Deficiency, Small for Gestational Age) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Recombinant Human Growth Hormone Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.HGH (Human Growth Hormone) Recombinant is a bioactive protein used in cell culture applications. HGH is a hormone that has a variety of effects. HGH binds to the GH receptor and has pleiotropic effects. One of the more than 250 Gibco® recombinant proteins available is recombinant human growth hormone (HGH).
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users).
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Novo Nordisk
- Ipsen
- Eli Lilly
- Pfizer
- Merck Serono
- Ferring Pharmaceuticals
- F.Hoffmann-La Roche
- GeneScience Pharmaceuticals
- LG Life Sciences
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Recombinant Human Growth Hormone Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Powder
o Solvent
· Recombinant Human Growth Hormone Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Growth Hormone Deficiency (GHD)
o Chronic Renal Insufficiency
o Turner Syndrome
o SHOX Deficiency
o Small for Gestational Age
· Recombinant Human Growth Hormone Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Novo Nordisk
o Ipsen
o Eli Lilly
o Pfizer
o Merck Serono
o Ferring Pharmaceuticals
o F.Hoffmann-La Roche
o GeneScience Pharmaceuticals
· Recombinant Human Growth Hormone Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Recombinant Human Growth Hormone Market, By Country
o U.S. Recombinant Human Growth Hormone Market
o Canada Recombinant Human Growth Hormone Market
o Mexico Recombinant Human Growth Hormone Market
o Europe
§ Europe Recombinant Human Growth Hormone Market, By Country
· Germany Recombinant Human Growth Hormone Market
o UK Recombinant Human Growth Hormone Market
o France Recombinant Human Growth Hormone Market
o RussiaRecombinant Human Growth Hormone Market
o Italy Recombinant Human Growth Hormone Market
o Rest of Europe Recombinant Human Growth Hormone Market
o Asia-Pacific
§ Asia-Pacific Recombinant Human Growth Hormone Market, By Country
o ChinaRecombinant Human Growth Hormone Market
o Japan Recombinant Human Growth Hormone Market
o South KoreaRecombinant Human Growth Hormone Market
o India Recombinant Human Growth Hormone Market
o Southeast AsiaRecombinant Human Growth Hormone Market
o Rest of Asia-Pacific Recombinant Human Growth Hormone Market
o South America
§ South AmericaRecombinant Human Growth Hormone Market
o Brazil Recombinant Human Growth Hormone Market
o ArgentinaRecombinant Human Growth Hormone Market
o ColumbiaRecombinant Human Growth Hormone Market
o Rest of South America Recombinant Human Growth Hormone Market
o Middle East and Africa
§ Middle East and AfricaRecombinant Human Growth Hormone Market
o Saudi ArabiaRecombinant Human Growth Hormone Market
o UAERecombinant Human Growth Hormone Market
o EgyptRecombinant Human Growth Hormone Market
o NigeriaRecombinant Human Growth Hormone Market
o South Africa Recombinant Human Growth Hormone Market
o Rest of MEA Recombinant Human Growth Hormone Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Recombinant Human Growth Hormone Market, By Type
5.1. Introduction
5.2. Global Recombinant Human Growth Hormone Revenue and Market Share by Type (2017-2021)
5.2.1. Global Recombinant Human Growth Hormone Revenue and Revenue Share by Type (2017-2021)
5.3. Powder
5.3.1. Global Powder Revenue and Growth Rate (2017-2021)
5.4. Solvent
5.4.1. Global Solvent Revenue and Growth Rate (2017-2021)
6. Recombinant Human Growth Hormone Market, By Application
6.1. Introduction
6.2. Global Recombinant Human Growth Hormone Revenue and Market Share by Application (2017-2021)
6.2.1. Global Recombinant Human Growth Hormone Revenue and Revenue Share by Application (2017-2021)
6.3. Growth Hormone Deficiency (GHD)
6.3.1. Global Growth Hormone Deficiency (GHD) Revenue and Growth Rate (2017-2021)
6.4. Chronic Renal Insufficiency
6.4.1. Global Chronic Renal Insufficiency Revenue and Growth Rate (2017-2021)
6.5. Turner Syndrome
6.5.1. Global Turner Syndrome Revenue and Growth Rate (2017-2021)
6.6. SHOX Deficiency
6.6.1. Global SHOX Deficiency Revenue and Growth Rate (2017-2021)
6.7. Small for Gestational Age
6.7.1. Global Small for Gestational Age Revenue and Growth Rate (2017-2021)
7. Recombinant Human Growth Hormone Market, By Region
7.1. Introduction
7.2. Global Recombinant Human Growth Hormone Revenue and Market Share by Regions
7.2.1. Global Recombinant Human Growth Hormone Revenue by Regions (2017-2021)
7.3. North America Recombinant Human Growth Hormone by Countries
7.3.1. North America Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2021)
7.3.2. North America Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Recombinant Human Growth Hormone by Countries
7.4.1. Europe Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2021)
7.4.2. Europe Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Recombinant Human Growth Hormone by Countries
7.5.1. Asia-Pacific Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Recombinant Human Growth Hormone by Countries
7.6.1. South America Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2021)
7.6.2. South America Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Recombinant Human Growth Hormone by Countries
7.7.1. Middle East and Africa Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Novo Nordisk
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Ipsen
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Eli Lilly
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Pfizer
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Merck Serono
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Ferring Pharmaceuticals
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. F.Hoffmann-La Roche
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. GeneScience Pharmaceuticals
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. LG Life Sciences
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.1. Global Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Recombinant Human Growth Hormone Market Forecast by Regions (2022-2027)
9.2.1. North America Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.1.1. United States Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.1.2. Canada Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.1.3. Mexico Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.2. Europe Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.2.1. Germany Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.2.2. France Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.2.3. UK Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.2.4. Russia Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.2.5. Italy Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.3. Asia-Pacific Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.3.1. China Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.3.2. Japan Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.3.3. Korea Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.3.4. India Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.4. South America Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.4.1. Brazil Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.4.2. Argentina Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.4.3. Columbia Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.4.4. Rest of South America Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5. Middle East and Africa Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5.3. Egypt Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5.4. Nigeria Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5.5. South Africa Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5.6. Turkey Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Recombinant Human Growth Hormone Market Forecast (2022-2027)
9.3. Recombinant Human Growth Hormone Market Forecast by Type (2022-2027)
9.3.1. Recombinant Human Growth Hormone Forecast by Type (2022-2027)
9.3.2. Recombinant Human Growth Hormone Market Share Forecast by Type (2022-2027)
9.4. Recombinant Human Growth Hormone Market Forecast by Application (2022-2027)
9.4.1. Recombinant Human Growth Hormone Forecast by Application (2022-2027)
9.4.2. Recombinant Human Growth Hormone Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Recombinant Human Growth Hormone Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Recombinant Human Growth Hormone Revenue and Revenue Share by Type (2017-2019)
Figure Global Powder Revenue and Growth Rate (2017-2019)
Figure Global Solvent Revenue and Growth Rate (2017-2019)
Table Global Recombinant Human Growth Hormone Revenue and Revenue Share by Application (2017-2019)
Figure Global Growth Hormone Deficiency (GHD) Revenue and Growth Rate (2017-2019)
Figure Global Chronic Renal Insufficiency Revenue and Growth Rate (2017-2019)
Figure Global Turner Syndrome Revenue and Growth Rate (2017-2019)
Figure Global SHOX Deficiency Revenue and Growth Rate (2017-2019)
Figure Global Small for Gestational Age Revenue and Growth Rate (2017-2019)
Table Global Recombinant Human Growth Hormone Revenue by Regions (2017-2019)
Figure North America Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure North America Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2019)
Figure North America Recombinant Human Growth Hormone by Countries (2017-2019)
Figure North America Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2019)
Figure United States Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure United States Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Canada Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Mexico Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Europe Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2019)
Figure Europe Recombinant Human Growth Hormone by Countries (2017-2019)
Figure Europe Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2019)
Figure Germany Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Germany Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure France Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure UK Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Russia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Italy Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Rest of Europe Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Asia-Pacific Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Recombinant Human Growth Hormone by Countries (2017-2019)
Figure Asia-Pacific Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2019)
Figure China Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure China Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Japan Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Korea Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure India Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Southeast Asia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure South America Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2019)
Figure South America Recombinant Human Growth Hormone by Countries (2017-2019)
Figure South America Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Brazil Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Argentina Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Columbia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Rest of South America Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Middle East and Africa Recombinant Human Growth Hormone Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Recombinant Human Growth Hormone by Countries (2017-2019)
Figure Middle East and Africa Recombinant Human Growth Hormone Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Saudi Arabia Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure United Arab Emirates Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Egypt Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Nigeria Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure South Africa Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Turkey Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Recombinant Human Growth Hormone Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2017-2019)
Table Novo Nordisk Recombinant Human Growth Hormone Financial Overview
Table Ipsen Recombinant Human Growth Hormone Financial Overview
Table Eli Lilly Recombinant Human Growth Hormone Financial Overview
Table Pfizer Recombinant Human Growth Hormone Financial Overview
Table Merck Serono Recombinant Human Growth Hormone Financial Overview
Table Ferring Pharmaceuticals Recombinant Human Growth Hormone Financial Overview
Table F.Hoffmann-La Roche Recombinant Human Growth Hormone Financial Overview
Table GeneScience Pharmaceuticals Recombinant Human Growth Hormone Financial Overview
Table LG Life Sciences Recombinant Human Growth Hormone Financial Overview
Figure Global Recombinant Human Growth Hormone Revenue (Millions USD) and Growth Rate (2019-2027)
Table Recombinant Human Growth Hormone Market Forecast by Regions (2019-2027)
Figure North America Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure United States Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Canada Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Mexico Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Europe Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Germany Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure France Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure UK Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Russia Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Italy Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Rest of Europe Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Asia-Pacific Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure China Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Japan Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Korea Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure India Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Southeast Asia Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure South America Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Brazil Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Argentina Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Columbia Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Rest of South America Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Middle East and Africa Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Saudi Arabia Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure United Arab Emirates Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Egypt Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Nigeria Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure South Africa Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Turkey Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Recombinant Human Growth Hormone Market Forecast (2019-2027)
Figure Global Recombinant Human Growth Hormone Forecast by Type (2019-2027)
Figure Global Recombinant Human Growth Hormone Market Share Forecast by Type (2019-2027)
Figure Global Recombinant Human Growth Hormone Forecast by Type (2019-2027)
Figure Global Recombinant Human Growth Hormone Forecast by Application (2019-2027)
Figure Global Recombinant Human Growth Hormone Market Share Forecast by Application (2019-2027)
Figure Global Recombinant Human Growth Hormone Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|